Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Glaxosmithkline Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 1,606.20 4.95  | 0.31% 19.45% 31.88 27,167.65
NSE Price: Nov 15, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 15, 15:58 1,606.20 4.95 0.31% 1,600.00 1,601.25 44,288 1,595.20 - 1,610.00
BSE Nov 15, 2019 1,603.70 2.45 0.15% 1,598.00 1,601.25 3,944 1,595.00 - 1,610.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 44,238 P/B: 11.57 NSE Code: GLAXO
52-Week Range: R 1,130.00 - 1,703.65 Dividend Yield: 1.25% BSE Code: 500660
TTM EPS: R 50.31 Book Value: R 138.61 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Lupin (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 37 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glaxosmithkline Pharma 6.00 12.07 32.92 19.45 6.51 2.43 6.97
S&P BSE Mid Cap -4.31 5.97 9.62 -1.46 7.24 7.78 8.68
S&P BSE Healthcare -6.61 5.33 3.92 -8.92 -5.00 -2.61 10.89
Company's return has been calculated on basis of NSE's price.
As on Nov 15, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.94 3.30 -
Net Profit 26.99 5.79 -
EPS 26.99 5.79 -
Book Value 4.01 -0.67 -
Average
Operating Margin 22.48 19.64 20.98
Net Margin 13.79 12.36 12.59
Return on Networth 21.22 18.19 19.65
Return on Investment 32.54 27.83 30.37
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 11.94 8.06 17.42
Operating Profit 7.06 16.60 -2.89
Net Profit 343.14 398.95 308.67
EPS 343.14 398.95 308.67
TTM
Revenue 2.07 8.06 3.78
Operating Profit 4.00 16.66 9.57
Net Profit 89.29 121.59 100.36
EPS 89.29 121.59 100.36
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glaxosmithkline Pharma 27,167.65 3,246.69 852.25 25.35 21.22 11.57 31.88
Lupin 33,604.24 17,689.22 318.63 1.77 4.55 2.47 107.09
Piramal Enterprises 35,140.16 14,278.56 1,708.87 11.71 4.28 1.32 17.01
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 30, 2017 GlaxoSmithK Line Pte Ltd  Buy Off Market 3,192,238 2,731.45 87,194.38
Mar 30, 2017 GlaxoSmithKline Pte Ltd  Sell Off Market 3,192,238 2,731.45 87,194.38
Mar 10, 2014 Glaxosmithkline Pte Ltd.  Buy Off Market 20,609,774 2,508.80 517,058.01
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Aditya Birla Sun Life Mutual Fund 2.960 2.758 2.574 2.427 2.339
Tata Mutual Fund 0.245 - - - -
UTI Mutual Fund 0.166 0.128 0.128 0.128 0.128
BNP Paribas Mutual Fund 0.041 - - - -
Mahindra Mutual Fund 0.021 0.022 0.022 0.013 -
Taurus Mutual Fund 0.011 - - - -
Nippon India Mutual Fund 0.006 0.003 0.003 - 0.001
Motilal Oswal Mutual Fund 0.001 - - - -
L&T Mutual Fund NA 0.074 0.178 0.204 0.204
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glaxosmithkline Pharmaceuticals Ltd.

Address: Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030 | Phone: 022-24959595 | Fax: 022-24959494

Email: [email protected]

Website: www.gsk-india.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
4.17
Piotroski F-Score
5
Modified C-Score
2
5-Years Price to Earnings
31.88
5-Years Price to Book
11.57
Earnings Yield
EBIT / Enterprise value
4.36%
PEG
Price / Earnings to growth ratio
2.26
Related Stocks
  Current Price   Chng %
Abbott India R12,365.00 +2.67%
Alkem Laboratories R2,058.25 +1.83%
Aurobindo Pharma R410.25 +3.65%
Bayer CropScience R3,366.45 +1.38%
Biocon R257.25 +1.00%
Cadila Healthcare R234.50 +0.11%
Lupin R742.25 +0.53%
Pfizer R3,980.75 -0.51%
Piramal Enterprises R1,766.95 +0.50%
Torrent Pharmaceuticals R1,782.15 +0.60%
As on Nov 15, 15:59